Strong of a unique large-scale vertical integration of Para Amino Phenol (PAP), Seqens EDS guarantees paracetamol supply despite raw material market volatility. Based in Wuxi (CN), our paracetamol is only 100 Km away from the key raw material, safeguarding the production of powder and directly compressible grades.

Seqens EDS has endlessly invested over the years in product diversity, production line extension, and in the training of the people to reach the best service and the highest standards requested for a GMP site

  • Vertical integration in PAP
  • 2 lines of DC 90 FB
  • New grades under qualifications: Paracetamol crystal/ fine crystal
  • Available grades without Croscarmellose, Paraben free


SEQENS has officially launched the project to build a new paracetamol production unit.

After a full year of R&D studies, SEQENS has officially launched the project to build a new paracetamol production unit, in partnership with Sanofi and UPSA and with the support of the France Relance programme. Innovative, competitive and environmentally friendly, the unit will have a capacity of 10,000 tonnes of paracetamol per year, will be built on the Roussillon platform (38) and will be commissioned in 2023.

Main paracetamol offer products

Our locations

Address Novacyl, Plateforme Chimique, Rue Gaston Monmousseau, CS 50032, Lieu-dit le Roussillon
38556 Roussillon
Business Line Salicylic acid & methyl salicylate
Market Pharmaceutical Synthesis
More information


  • 20 kt Salicylic ACid
  • 6 kt Methyl Salicilate

Last inspections:

  • ANSM, February 2018
  • FDA, June 2016
  • ISO, March 2018


Address Novacyl (Wuxi) Pharmaceutical Co. Ltd., 16, Guangshi Road, Meijing Village, Luoshe Town, Huishan District
214185 Wuxi
Business Line Paracetamol
Phone +86 510 8101 9200
Market Pharmaceutical
More information

Surface: 38, 619 m²

Lab surface: 560 m²


  • 8 KT of Paracetamol
  • 4.5 KT of DC range

Flagship technologies: 

  • Acetylation reaction
  • Refining, granulation

Last inspections: 

  • ANSM, January 2018
  • NMPA ,August 2018